Regulatory Strategy and Roadmap

A promising product needs a regulatory strategy that connects scientific evidence, manufacturing plans, and clinical objectives.

I help biotechnology and pharmaceutical teams define practical development pathways, identify gaps early, and prioritize the activities needed for their next milestone. My approach considers your product, available evidence, resources, and intended markets.

• Product classification and regulatory pathway assessment.
• Integrated clinical, nonclinical, and CMC gap assessments.
• US and international development planning.
• Assessment of designation and expedited development opportunities.
• Submission sequencing and health authority interaction planning.
• Regulatory risk assessment and mitigation.
• Development roadmaps with responsibilities and decision points.

A tailored regulatory strategy, prioritized gap assessment, risk register, and milestone roadmap that your team can use to guide execution.